Abstract
Heterocyclic amines (HAs) present in cooked meat (PhIP and MelQx) are activated only by CYP1A2 in the liver of most species, including man. This enzyme exhibits marked interindividual differences in its expression, due to induction and possibly also genetically. The absence of CYP1A2 appears to protect from HA- (PhIP and MelQx) induced cancer, as exemplified by results in the cynomolgus monkey. Differences in the potency of these HAs are not due to differences in the kinetics of their activation. The catalytic efficiency of CYP1A2 towards HAs and their oxidative fate varies amongst species, in both cases increasing the susceptibility of humans compared to that of the rat. Interindividual and inter-organ differences in the further metabolism of N-hydroxy-HAs appear to be important determinants of cancer susceptibility, as does the glutathione S- transferase catalysed detoxication of esters of N-hydroxy-PhlP. There is a need for an effective means of quantifying the in vivo activation of HAs in man to enable the possible risk posed by these compounds to be assessed effectively.
Keywords
- Cynomolgus Monkey
- Human Liver Microsome
- Accelerator Mass Spectrometry
- Heterocyclic Amine
- CYPIA2 Expression
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aguilar F, Hussain SP, Cerutti P (1993) Aflatoxin B1 induces the transversion of G->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci USA 90: 8586–8590
Alexander J, Fossum BH, Holme JA (1994) Metabolism of the food mutagen 2-amino-l- methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in isolated liver cells from guinea pig, hamster, mouse and rat. Environ Health Perspect 102 (Suppl 6): 109–114
Alexander J, Wallin H, Home JA, Becher G (1989) 4-(2-Amino-1-methylimidazo [4,5- b]pyrid-6-yl)phenyl sulfate - a major metabolite of the food mutagen 2-amino-l- methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Carcinogenesis 10:1543–1547
Bogaards JJ, Verhagen H, Willems MI, van Poppel G, van Bladeren PJ (1994) Consumption of Brussels sprouts results in elevated alpha-class glutathione S- transferase levels in human blood plasma. Carcinogenesis 15: 1073–1075
Boobis AR, Gooderham NJ, Rich KJ, Zhao K, Edwards RJ, Murray BP, Lynch AM, Murray S, Davies DS (1995) Enzymatic studies of the activation of heterocyclic food mutagens in man. In: Adamson RH, Gustafsson J-A, Ito N, Nagao M, Sugimura T, Wakabayashi K, Yamazoe Y (eds) Heterocyclic amines in cooked foods: possible human carcinogens. Princeton Scientific Publishing Co, Princeton, NJ, pp 134–144
Brooks RA, Gooderham NJ, Zhao K, Edwards RJ, Howard LA, Boobis AR, Winton DJ (1994) 2-Amino-l-methyl-6-phenylimidazo[4,5-b]pyridine is a potent mutagen in the mouse small intestine. Cancer Res 54:1665–1671
Buchthal J, Grund KE, Buchmann A, Schrenk D, Beaune P, Bock KW (1995) Induction of cytochrome P4501A by smoking or omeprazole in comparison with UDP- glucuronosyltransferase in biopsies of human duodenal mucosa. Eur J Clin Pharmacol 47: 431–435
Buonarati M H, Felton J S (1990) Activation of 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) to mutagenic metabolites. Carcinogenics 11: 1133–1138
Buonarati MH, Roper M, Morris CJ, Happe JA, Knize MG, Felton JS (1992) Metabolism of 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice. Carcinogeneses 13: 621–627
Buonarti MH, Turteltaub KW, Shen NH, Felton JS (1990) Role of sulfation and acetylation in the activation of 2-hy droxamino-1-methyl-6-phenylimidazo [4,5- bjpyridineto intermediates which bind to DNA. Carcinogenesis 11: 1133–1138
Butler MA, Iwasaki M, Guengerich FP, Kadlubar FF (1989) Human cytochrome P450PA (P4501A2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3- demethylation of caffeine and the N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci USA 86: 7696–7700
Clarke SE, Ayrton AD, Chenery RJ (1994) Characterization of the inhibition of P4501A2 by furafyiline. Xenobiotica 24: 517–526
Davis CD, Schut HA, Snyderwine EG (1993) Enzymatic phase II activation of the N- hydroxylamines of IQ, MeIQx and PhIP by various organs of monkeys and rats. Carcinogenesis 14: 2091–2096
Edwards RJ, Murray BP, Murray S, Schultz T, Neubert D, Gant TW, Thorgeirsson SS, Boobis AR, Davies DS (1994) Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human. Carcinogenesis 15: 829–836
Edwards RJ, Singleton AM, Murray BP, Davies DS, Boobis AR (1995) Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes. Biochem Pharmacol 49: 39–47
Felton JS, Knize MG (1991) Occurrence, identification and bacterial mutagenicity of heterocyclic amines in cooked food. Mutat Res 259: 205–217
Felton JS, Knize MG, Shen NH, Andresen BD, Bjeldanes LF, Hatch FT (1986) Identification of mutagens in cooked beef. Environ Health Perspect 67: 17–24
Friesen MD, Kaderlink K, Lin D, Garren L, Bartsch H, Lang NP, Kadlubar FF (1994) Analysis of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-bjpyridine in rat and human tissues by alkaline hydrolysis and gas chromatography/electron capture mass spectrometry: validation by comparison with 32P-postlabeling. Chem Res Toxicol 7: 733–739
Fuhr U, Doehmer J, Battula N, Wolfel C, Kudla C, Keita Y, Staib AH (1992) Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Biochem Pharmacol 43: 225–235
Gerhardsson de Verdier M, Hagman U, Peters RK, Steineck G, Overvik E (1991) Meat, cooking methods and colorectal cancer: A case-referent study in Stockholm. Intl J Cancer Res 49: 520–525
Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC (1994) Intake of fat, meat and fiber in relation to risk of colon cancer in men. Cancer Res 54: 2390–2397
Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC (1994) Intake of fat, meat and fiber in relation to risk of colon cancer in men. Cancer Res 54: 2390–2397
Harris CC, Weston A, Willey JC, Trivers GE, Mann DL (1987) Biochemical and molecular epidemiology of human cancer; Indicators of carcinogen exposure, DNA damage, and genetic predisposition. Environ Health Perspect 75: 109–119
Hayashi S, Watanabe J, Nakachi K, Eguchi H, Gotoh O, Kawajiri K (1994) Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis 15: 801–806
Ito N, Hasegawa R, Sano M, Tamano S, Esumi H, Takayama S, Sugimura T (1991) A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 12: 1503–1506
Kaderlik KR, Mulder GJ, Shaddock JG, Casciano DA, Teitel CH, Kadlubar FF (1994) Effect of glutathione depletion and inhibition of glucuronidation and sulfation on 2- amino-l-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism, PhlP-DNA adduct formation and unscheduled DNA synthesis in primary rat hepatocytes. Carcinogenesis 15: 1711–1716
Kakiuchi H, Watanabe M, Ushijima T, Toyota M, Imai K, Weisburger JH, Sugimura T, Nagao M (1995) Specific 5′-GGGA-3′->5′-GGA-3′ mutation of the Ape gene in rat colon tumors induced by 2-amino-l-methyl-6-phenylimidazo[4,5,-b]pyridine. Proc Natl Acad Sci USA 92: 910–914
Kato R, Yazmazoe Y (1987) Metabolic activation and covalent binding to nucleic acids of carcinogenic heterocy lie amines from cooked foods and amino acid pyrolysates. Jpn J Cancer Res 78: 297–311
Kerdar RS, Fasshauer I, Probst M, Blum M, Meyer UA, Wild D (1993) 32P-Postlabeling studies on the DNA adducts of the food mutagens/carcinogens IQ and PhlP-adduct formation in a chemical system, and by rat and human metabolism. LARC Sci Publ 124:173–179
Lang NP, Butler MA, Massengill J, Lawson M, Stotts RC, Hauer-Jensen M, Kadlubar FF (1994) Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomark Prevent 3: 675–682
Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF (1994) Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis. Cancer Res 54: 4920–4926
Lodovici M, Dolara P, Caderni G, Carini M, Costantini A, Selli C, Barbagli G, Calzolai A. (1983) The effect of cigarette smoke on aryl-hydrcarbon hydroxylase (AHH) activity of the human kidney. Eur J Cancer Clin Oncol 19: 1565–1568
Lynch AM, Murray S, Boobis AR, Davies DS, Gooderham NJ (1991) The measurement of MeIQx adducts with mouse haemoglobin in vitro and in vivo: implications for human dosimetry. Carcinogenesis 12: 1067–1072
Lynch AM, Murray S, Zhao K, Gooderham NJ, Boobis AR, Davies DS (1993) Molecular dosimetry of the food-borne carcinogen MeIQx using adducts of serum albumin. Carcinogenesis 14: 191–194
McKinnon RA, McManus ME (1995) Function and localization of cytochromes P450 involved in the metabolic activation of food-derived heterocyclic amines. In: Adamson RH, Gustafsson J-Å, Ito N, Nagao M, Sugimura T, Wakabayashi K, Yamazoe Y (eds) Heterocyclic amines in cooked foods: possible human carcinogens. Princeton Scientific Publishing Co, Princeton, NJ, pp 145–153
McKinnon RA, Burgess WM, Hall P de la M, Zaiminuddin A-A, McManus ME (1992) Metabolism of food-derived heterocyclic amines in human and rabbit tissues by P4503A proteins in the presence of flavonoids. Cancer Res 52(Suppl):2108s–2113s
McKinnon RA, Hall P de la M, Quattrochi LC, Tukey RH, McManus ME (1991) Localization of CYP1A1 and CYP1A2 messenger RNA in normal human liver and in hepatocellular carcinoma by in situ hybridization. Hepatology 14: 848–856
Morel F, Fardel O, Meyer DJ, Langouet S, Gilmore KS, Meunier B, Tu CP, Kensler TW, Ketterer B, Guillouzo A (1993) Preferential increase of glutathione S-transferase class alpha transcripts in cultured human hepatocytes by phenobarbital, 3- methylcholanthrene, and dithiolethiones. Cancer Res 53: 231–234
Morgenthaler P-ML, Holzhauser D (1995) Analysis of mutations induced by 2-amino-l- methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in human lymphoblastoid cells. Carcinogenesis 16: 713–718
Murray BP, Edwards RJ, Murray S, Singleton AM, Davies DS, Boobis AR (1993) Human hepatic CYP1A1 and CYP1A2 content, determined with specific anti-peptide antibodies, correlates with the mutagenic activation of PhIP. Carcinogenesis 14: 585–592
Nagao M, Fujita Y, Wakabayashi K, Sugimura T (1983) Ultimate forms of mutagenic and carcinogenic heterocyclic amines produced by pyrolysis. Biochem Biophys Res Commun 114: 626–631
Nakajima M, Yokoi T, Mizutani M, Shin S, Kadlubar FF, Kamataki T (1994) Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites, absence of mutation prescribing the phenotype in the CYP1A2 Gene. Cancer Epidemiol Biomark Prevent 3: 413–421
Nakajima T, Elovaara E, Anttila S, Hirvonen A, Camus AM, Hayes JD, Ketterer B, Vainio H (1995) Expression and polymorphism of glutathione S-transferase in human lungs, risk factors in smoking-related lung cancer. Carcinogenesis 16: 707–711
Nijhoff WA, Bosboom MA, Smidt MH, Peters WH (1995) Enhancement of rat hepatic and gastrointestinal glutathione and glutathione S-transferases by alpha-angelicalactone andflavone. Carcinogenesis 16: 607–612
Ozawa S, Chou HC, Kadlubar FF, Nagata K, Yamazoe Y, Kato R (1994) Activation of 2- hydroxyamino-l-methyl-6-phenylimidazo[4,5-b]pyridine by cDNA-expressed human and rat arylsulfotransferases. Jpn J Cancer Res 85: 1220–1228
Potter JD, McMichael AJ (1986) Diet and cancer of the colon and rectum: a case-control study. J Natl Cancer Inst 76: 557–569
Rich KJ, Murray BP, Lewis I, Rendell NB, Davies DS, Gooderham NJ, Boobis AR (1992) N-Hydroxy-MelQx is the major microsomal oxidation product of the dietary carcinogen MelQx with human liver. Carcinogenesis 13: 2221–1226
Schiffman MH, Felton JS (1990) Fried foods and the risk of colon cancer. Am J Epidemiol 131: 376–378
Sesardic D, Boobis AR, Murray BP, Murray S, Segura J, de la Torre R, Davies DS (1990) Furafylline is a specific and potent inhibitor of cytochrome P450IA2 in man. Br J Clin Pharmacol 29: 651–663
Sesardic D, Cole KJ, Edwards RJ, Davies DS, Thomas PE, Levin W, Boobis AR (1990) The inducibility and catalytic activity of cytochromes P450c and P450d in rat tissues. Biochem Pharmacol 39: 499–506
Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP (1994) Interindividual variations in human liver cyctochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270: 414–423
Snyderwine EG, Turesky RJ, Buonarati MH, Turteltaub KW, Adamson RH (1995) Metabolic processing and disposition of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates. In: Adamson RH, Gustafsson J-Å, Ito N, Nagao M, Sugimura T, Wakabayashi K, Yamazoe Y (eds) Heterocyclic amines in cooked foods: possible human carcinogens. Princeton Scientific Publishing Co, Princeton, NJ, pp 69–77
Sugimura T (1985) Carcinogenicity of mutagenic heterocylic amines formed during the cooking process. MutatRes 150: 33–41
Sugimura T (1995) History, present and future, of heterocyclic amines, cooked food mutagens. In: Adamson RH, Gustafsson J-A, Ito N, Nagao M, Sugimura T, Wakabayashi K, Yamazoe Y (eds) Heterocyclic amines in cooked foods: possible human carcinogens. Princeton Scientific Publishing Co, Princeton, NJ, pp 214–231
Turesky RJ, Aeschbacher HU, Wiirzner HP, Skipper PL, Tannenbaum SR (1988) Major routes of metabolism of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5- f]quinoxaline in the rat. Carcinogenesis 9: 1043–1048
Turesky RJ, Lang NP, Butler MA, Teitel CH, Kadlubar FF (1991) Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 12: 1839–1845
Turesky RJ, Markovic J, Bracco-Hammer I, Fay LB (1991) The effect of dose and cytochrome P450 induction on the metabolism and disposition of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in the rat. Carcinogenesis 12: 1847–1855
Turteltaub KW, Vogel JS, Frantz C, Felton JS, McManus M (1995) Assessment of the DNA adduction and pharmacokinetics of PhIP and MeIQx in rodents at doses approximating human exposure using the technique of accelerator mass spectrometry (AMS) and 32P-postlabeling. In: Adamson RH, Gustafsson J-Å, Ito N, Nagao M, Sugimura T, Wakabayashi K, Yamazoe Y (eds) Heterocyclic amines in cooked foods: possible human carcinogens. Princeton Scientific Publishing Co, Princeton, NJ, pp 93–102
Wakabayashi K, Nagao M, Esumi H, Sugimura T (1992) Food-derived mutagens and carcinogens. Cancer Res (Suppl) 52:2092s–2098s
Wallin H, Mikalsen A, Guengerich FP, Ingelman-Sundberg M, Solberg KE, Rossland OJ, Alexander J (1990) Differential rates of metabolic activation and detoxication of the food mutagen 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine by different cytochrome P450 enzymes. Carcinogenesis 11: 489–492
Winton DJ, Blount MA, Ponder BAJ (1988) A clonal marker induced by mutation in mouse intestinal epithelium. Nature 333: 463–466
Winton DJ, Gooderham NJ, Boobis AR, Davies DS, Ponder BAJ (1990) Mutagenesis of mouse intestine in vivo using the Dlb-1 specific locus test: studies with 1,2- dimethylhydrazine, dimethylnitrosamine, and the dietary mutagen 2-amino-3,8- dimethylimidazo[4,5-f]quinoxaline. Cancer Res 50: 7992–7996
Yoshikawa M, Arashidani K, Kawamoto T, Kodama Y (1994) Aryl hydrocarbon hydroxylase activity in human lung tissue: in relation to cigarette smoking and lung cancer. Environ Res 65: 1–11
Zhao K, Murray S, Davies DS, Boobis AR, Gooderham NJ (1994) Metabolism of the food derived mutagen and carcinogen 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by human liver microsomes. Carcinogenesis 15 (6): 1285–1288
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Boobis, A.R. et al. (1996). Enzymic and Interindividual Differences in the Human Metabolism of Heterocyclic Amines. In: Seiler, J.P., Kroftová, O., Eybl, V. (eds) Toxicology - From Cells to Man. Archives of Toxicology, vol 18. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61105-6_28
Download citation
DOI: https://doi.org/10.1007/978-3-642-61105-6_28
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64696-6
Online ISBN: 978-3-642-61105-6
eBook Packages: Springer Book Archive